In The News

Judge Kicks FDA-Approved Drug Off the Market in Patent Dispute

The National Law Journal

06 Jan 2017

Michael Jacobs, co-founder and currently co-chair of the firm’s Intellectual Property Practice Group, was quoted in The National Law Journal article “Judge Kicks FDA-Approved Drug Off the Market in Patent Dispute” regarding U.S. District Judge Sue Robinson of Delaware ordering an FDA-approved cholesterol drug off the market.

“There are key differences between the three [other injunction] cases, but Morrison & Foerster partner Michael Jacobs said they could signal the beginning of a shift in district court willingness to enjoin infringers, at least in life science cases. ‘It may be easier than in electronics cases to demonstrate irreparable harm,’ Jacobs said. It also could be that lawyers are getting savvier at making their cases for injunctions, he said.”



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.